Multiplexing In Tissue-Based Research: Chromogenic Staining and Automation
Immunohistochemistry ( IHC ) detects proteins of interest within whole tissue sections, keeping cellular organization intact. Evolving from conventional IHC (single slide, single marker), multiplex IHC is an advancement on this technique that enables the detection of multiple markers of interest simultaneously in one tissue section.
The ability to analyze multiple markers is important as cells do not exist or act in isolation, and cellular responses involve activation of several pathways that influences the nature of their responses.
Multiplexing can therefore be applied to address several types of research questions including, but not limited to, the spatial arrangement or quantity of different cell lineages, phenotyping of immune cells, evaluation of multiple effectors of signal transduction pathways, and the distribution of novel drugs.
Using single-plex, chromogenic IHC, they showed that the density of PD-L1+ cells correlated with a better response to immunotherapy, as did an increased density and spatial proximity of PD-1+ lymphocytes to PD-L1+ cells. Using a multiplex panel and the BOND RX stainer, Giraldo et al1 were able to determine that the PD-1+ cells consisted of several different immune cell types including CD8, CD4, Foxp3 T-cells, and some CD20 B-cells. Their findings suggest that multiple immune cell types may be involved in tumor regression of Merkel cell carcinoma, that could lead to uncovering important mechanisms involved in therapeutic responses. Overall, their study highlights that IHC is an important tool for cancer research. It also demonstrates that multiplex IHC can reveal important features of such a heterogenous and complex disease that can unveil potential mechanisms, biomarkers, as well as paving the way for further directed research.
Although immunofluorescent multiplexing has been the most popular method of choice to date, chromogenic multiplexing with 3+ markers is becoming a more viable option as there are now more commercially available chromogens and color choices. This results in a permanent, multi-color slide that can be imaged and scanned with brightfield microscopes/scanners to generate a complex biological picture.
Performing IHC manually may spark dread due to the lengthy nature of the process, however Leica Biosystems offers a flexible, consistent, fully automated solution that decreases hands-on time for up to 6-plex chromogenic staining. Automation with the BOND RX stainer offers the following advantages for staining:
Download the poster to find out more about chromogenic multiplexing on the BOND RX fully automated stainer for up to 6-plex chromogenic staining.
This article was created for Research Link, Leica Biosystems life science newsletter. Like what you read?
- Giraldo N A, Nguyen P, Engle E L, et al. Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. J. Immunotherapy Cancer. 2018;6;99. https://doi.org/10.1186/s40425-018-0404-0
El contenido de Leica Biosystems Knowledge Pathway está sujeto a las condiciones de uso del sitio web de Leica Biosystems, disponibles en: Aviso legal. El contenido, incluidos los webinars o seminarios web, los recursos de formación y los materiales relacionados, está destinado a proporcionar información general sobre temas concretos de interés para los profesionales de la salud y no está destinado a ser, ni debe interpretarse como asesoramiento médico, normativo o jurídico. Los puntos de vista y opiniones expresados en cualquier contenido de terceros reflejan los puntos de vista y opiniones personales de los ponentes/autores y no representan ni reflejan necesariamente los puntos de vista ni opiniones de Leica Biosystems, sus empleados o sus agentes. Cualquier enlace incluido en el contenido que proporcione acceso a recursos o contenido de terceros se proporciona únicamente por comodidad.
Para el uso de cualquier producto, debe consultarse la documentación correspondiente del producto, incluidas las guías de información, los prospectos y los manuales de funcionamiento.
Copyright © 2022 Leica Biosystems division of Leica Microsystems, Inc. y sus filiales de Leica Biosystems. Todos los derechos reservados. LEICA y el logotipo de Leica son marcas comerciales registradas de Leica Microsystems IR GmbH.